News - Page 321

TLDR: Venture capital invested $2.4 billion in cryptocurrency startups in Q1 2024. DeFi and NFTs are leading trends in cryptocurrency investments. Despite regulatory uncertainty and market fluctuations, the cryptocurrency industry saw a

TLDR: Scale AI raises $1 billion in late-stage fundraise led by Accel Top tech companies like Nvidia, Amazon, and Meta are investing in AI startups Scale AI, a data startup based in

TLDR: Scale AI raises $1 billion in a late-stage funding round led by Accel, with participation from tech giants Nvidia, Amazon, and Meta. The AI data startup is now valued at nearly

TLDR: Key Points: US startups have seen a surge in $100M+ funding rounds in 2024. Sectors like biotech, healthcare, and cybersecurity are leading the charge in securing these megadeals. Megadeals have seen

TLDR: Zack Ellison from Applied Real Intelligence discusses the importance of market and industry analysis in evaluating industries for venture lending. Market and industry analysis are crucial in determining the potential success

TLDR: LabGenius secures €40.9M in Series B funding led by Amsterdam’s M Ventures to advance drug discovery platform EVA, LabGenius’ discovery platform, integrates AI, robotic automation, and synthetic biology to develop therapeutic

TLDR: Money managers are converging on Abu Dhabi, leading to a doubling in assets under management in the first quarter. ADNOC, the UAE’s state-owned energy company, is expanding its international footprint by

TLDR: SanchiConnect and YourNest Venture Capital launched an accelerator program for deeptech start-ups. The program will provide selected start-ups with essential resources, mentorship, and funding. SanchiConnect and YourNest Venture Capital have joined

TLDR: Key points: Egyptian VC firm Glint completes first close of its second venture fund at $3 million. Fund will invest in early-stage startups in Egypt, with tickets ranging from $250,000 to

TLDR: Liz Kettler, former CFO of OpenView, joins Pillar VC as the new CFO. Pillar VC, a Boston venture capital firm, focuses on early-stage biotech and deep tech investment. Liz Kettler has